79 related articles for article (PubMed ID: 32691963)
1. Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies.
Aydin G; Paksoy MN; Orhan MD; Avsar T; Yurtsever M; Durdagi S
Chem Biol Drug Des; 2020 Jul; 96(1):684-700. PubMed ID: 32691963
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
3. Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators.
Lotfy G; Abdel Aziz YM; Said MM; El Ashry ESH; El Tamany ESH; Abu-Serie MM; Teleb M; Dömling A; Barakat A
Bioorg Chem; 2021 Dec; 117():105427. PubMed ID: 34794098
[TBL] [Abstract][Full Text] [Related]
4. Identification of small molecular inhibitors of SIRT3 by computational and biochemical approaches a potential target of breast cancer.
Ullah A; Rehman NU; Islam WU; Khan F; Waqas M; Halim SA; Jan A; Muhsinah AB; Khan A; Al-Harrasi A
Sci Rep; 2024 May; 14(1):12475. PubMed ID: 38816444
[TBL] [Abstract][Full Text] [Related]
5. The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models.
Wang W; Qin JJ; Voruganti S; Srivenugopal KS; Nag S; Patil S; Sharma H; Wang MH; Wang H; Buolamwini JK; Zhang R
Nat Commun; 2014 Oct; 5():5086. PubMed ID: 25271708
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyrimidine derivatives as MDM2 inhibitors.
Mehri A; Mahnam K; Sirous H; Aghaei M; Rafiei L; Rostami M
Chem Biol Drug Des; 2024 Jan; 103(1):e14399. PubMed ID: 38011915
[TBL] [Abstract][Full Text] [Related]
7. Identification of small molecule inhibitors of RAD52 for breast cancer therapy: in silico approach.
Kumar M; Dubey R; Kumar Shukla P; Dayal D; Kumar Chaubey K; Tsai LW; Kumar S
J Biomol Struct Dyn; 2024 Jun; 42(9):4605-4618. PubMed ID: 37288783
[TBL] [Abstract][Full Text] [Related]
8. High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitors.
Veeramachaneni GK; Raj KK; Chalasani LM; Bondili JS; Talluri VR
Drug Des Devel Ther; 2015; 9():4397-412. PubMed ID: 26273199
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoinformatics approach for the screening of Kovidra
More-Adate P; Lokhande KB; Shrivastava A; Doiphode S; Nagar S; Singh A; Baheti A
J Biomol Struct Dyn; 2024 May; 42(8):4263-4282. PubMed ID: 37288734
[TBL] [Abstract][Full Text] [Related]
10. Probing Protein Surfaces: QSAR Analysis with Helix Mimetics.
Azzarito V; Rowell P; Barnard A; Edwards TA; Macdonald A; Warriner SL; Wilson AJ
Chembiochem; 2016 Apr; 17(8):768-73. PubMed ID: 26690307
[TBL] [Abstract][Full Text] [Related]
11. Discovery of anti-colon cancer agents targeting wild-type and mutant p53 using computer-aided drug design.
Hadni H; Elhallaoui M
J Biomol Struct Dyn; 2023 Nov; 41(19):10171-10189. PubMed ID: 36533393
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay.
Ji JZ; Lao KJ; Hu J; Pang T; Jiang ZZ; Yuan HL; Miao JS; Chen X; Ning SS; Xiang H; Guo YM; Yan M; Zhang LY
Acta Pharmacol Sin; 2014 Aug; 35(8):1082-92. PubMed ID: 25047514
[TBL] [Abstract][Full Text] [Related]
13. A computational analysis of the binding model of MDM2 with inhibitors.
Hu G; Wang D; Liu X; Zhang Q
J Comput Aided Mol Des; 2010 Aug; 24(8):687-97. PubMed ID: 20490618
[TBL] [Abstract][Full Text] [Related]
14. BRCA1/TP53 tumor proteins inhibited by novel analogues of curcumin - Insight from computational modelling, dynamic simulation and experimental validation.
Aloor LJ; Skariyachan S; Raghavamenon AC; Kumar KM; Narayanappa R; Uttarkar A; Niranjan V; Cherian T
Int J Biol Macromol; 2023 Dec; 253(Pt 4):126989. PubMed ID: 37739292
[TBL] [Abstract][Full Text] [Related]
15. Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination.
van der Vlag R; Yagiz Unver M; Felicetti T; Twarda-Clapa A; Kassim F; Ermis C; Neochoritis CG; Musielak B; Labuzek B; Dömling A; Holak TA; Hirsch AKH
ChemMedChem; 2020 Feb; 15(4):370-375. PubMed ID: 31774938
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
Lee OW; Austin S; Gamma M; Cheff DM; Lee TD; Wilson KM; Johnson J; Travers J; Braisted JC; Guha R; Klumpp-Thomas C; Shen M; Hall MD
SLAS Discov; 2020 Jan; 25(1):9-20. PubMed ID: 31498718
[TBL] [Abstract][Full Text] [Related]
17. Small-Molecule Inhibitors of TIPE3 Protein Identified through Deep Learning Suppress Cancer Cell Growth In Vitro.
Chen X; Lu Z; Xiao J; Xia W; Pan Y; Xia H; Chen YH; Zhang H
Cells; 2024 Apr; 13(9):. PubMed ID: 38727307
[TBL] [Abstract][Full Text] [Related]
18. Virtual Screening of Small Molecules Targeting BCL2 with Machine Learning, Molecular Docking, and MD Simulation.
Tondar A; Sánchez-Herrero S; Bepari AK; Bahmani A; Calvet Liñán L; Hervás-Marín D
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785951
[TBL] [Abstract][Full Text] [Related]
19. Computational exploration of novel ROCK2 inhibitors for cardiovascular disease management; insights from high-throughput virtual screening, molecular docking, DFT and MD simulation.
Ali I; Iqbal MN; Ibrahim M; Haq IU; Alonazi WB; Siddiqi AR
PLoS One; 2023; 18(11):e0294511. PubMed ID: 37972144
[TBL] [Abstract][Full Text] [Related]
20. Checking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug Repurposing.
Jamal S; Goyal S; Shanker A; Grover A
PLoS One; 2015; 10(6):e0129370. PubMed ID: 26066505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
